Home > Insider Trading > Filing (0001372353-16-000001)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1168220	Uluru Inc.	ULUR	Pharmaceutical Preparations (2834)	412118656

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372353	K Terrance Wallberg	C/O Uluru Inc. 4452 Beltway Drive Addison TX 75001	Chief Financial Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.001	Acquisiton	2016-03-29	701,262	$0.07	825,519	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to purchase common stock, par value $0.001	Acquisiton	2016-03-29	701,262	$0.09	701,262	$0.09

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
701,262	2016-03-29	2021-03-29	No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Warrant to purchase common stock, par value $0.001	$0.60	2013-09-10	2018-03-14	60,000	60,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$1.15		2024-09-25	40,000	40,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$0.33		2023-03-20	90,000	90,000	Direct
Common Stock	Employee Stock Option (Right to Buy)	$34.65		2018-02-12	5,334	5,334	Direct
Common Stock	Employee Stock Option (Right to Buy)	$14.25		2016-12-06	13,334	13,334	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2018-03-14	60,000	60,000	Direct
2024-09-25	40,000	40,000	Direct
2023-03-20	90,000	90,000	Direct
2018-02-12	5,334	5,334	Direct
2016-12-06	13,334	13,334	Direct

Footnotes

Under a Stock Purchase Agreement, dated as of March 29, 2016, with the Company and certain other investors, Mr. Wallberg purchased 701,262 shares of the Company's common stock at a purchase price of $0.0713 per share and was issued a warrant to acquire up to 701,262 shares of the Company's common stock (as reported in this Form 4) for no additional consideration.
On March 14, 2013, Mr. Wallberg purchased 100,000 shares of the Company's common stock at a purchase price of $0.40 per share with the purchase taking place at four closings over a twelve month period and was issued a warrant to acquire up to 60,000 shares of the Company's common stock (as reported in this Form 4) for no additional consideration.
This employee stock option will become exercisable with respect to 40,000 shares of the Company's common stock over a three year period.
This employee stock option became exercisable with respect to 52,500 shares of the Company's common stock on September 25, 2014 and will become exercisable with respect to an additional 37,500 shares of the Company's common stock over an eighteen month period.
This employee stock option became fully vested on February 12, 2012.
This employee stock option became fully vested on December 6, 2010.